相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Direct evidence of 2-cyano-2-propoxy radical activity during AIBN-based oxidative stress testing in acetonitrile-water solvent systems
Michael A. Watkins et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Implications of In-Use Photostability: Proposed Guidance for Photostability Testing and Labeling to Support the Administration of Photosensitive Pharmaceutical Products, Part 1: Drug Products Administered by Injection
Steven W. Baertschi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Risk Assessment of Genotoxic Impurities in New Chemical Entities: Strategies To Demonstrate Control
Andrew Teasdale et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2013)
Best Practices for Drug Substance Stress and Stability Studies During Early-Stage Development Part II-Conducting Abbreviated Long-Term and Accelerated Stability Testing on the First Clinical Drug Substance Batch to Confirm and Adjust the Drug Substance Retest Period/Powder for Oral Solution Shelf Life
Q. Chan Li et al.
JOURNAL OF PHARMACEUTICAL INNOVATION (2013)
Guidelines and pharmacopoeial standards for pharmaceutical impurities: Overview and critical assessment
David J. Snodin et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2012)
Best Practices for Drug Substance Stress and Stability Studies During Early-Stage Development Part I-Conducting Drug Substance Solid Stress to Support Phase Ia Clinical Trials
Q. Chan Li et al.
JOURNAL OF PHARMACEUTICAL INNOVATION (2012)
Impact of metal-induced degradation on the determination of pharmaceutical compound purity and a strategy for mitigation
Sally K. Dotterer et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2011)
Artifactual formylation of the secondary amine of duloxetine hydrochloride by acetonitrile in the presence of titanium dioxide: Implications for HPLC method development
M. J. Skibic et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
Analytical control of process impurities in Pazopanib hydrochloride by impurity fate mapping
Yan Li et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
Identification and control of metal-chelating chromatographic artifacts in the analysis of a malonohydrazide derivative drug compound
Shaoping Yang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
A Critical Assessment of the ICH Guideline on Photostability Testing of New Drug Substances and Products (Q1B): Recommendation for Revision
Steven W. Baertschi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Recent trends in the impurity profile of pharmaceuticals
Kavita Pilaniya et al.
JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH (2010)
A Quantitative Kinetic Study of Polysorbate Autoxidation: The Role of Unsaturated Fatty Acid Ester Substituents
Jia Yao et al.
PHARMACEUTICAL RESEARCH (2009)
Phase Behavior of ranitidine HCl in the presence of degradants and atmospheric moisture - Impact on chemical stability
Peter P. Guerrieri et al.
LANGMUIR (2008)
Identification of an unknown extraneous contaminant in pharmaceutical product analysis
Mingxiang Lin et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2007)
Strategies for the investigation and control of process-related impurities in drug substances
Mark D. Argentine et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Photosensitized degradation of losartan potassium in an extemporaneous suspension formulation
Randal A. Seburg et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2006)
Ionization states in the microenvironment of solid dosage forms: Effect of formulation variables and processing
Ramprakash Govindarajan et al.
PHARMACEUTICAL RESEARCH (2006)
Formation and reactivity of free radicals in 5-hydroxymethyl-2-furaldehyde - the effect on isoprenaline photostability
J Brustugun et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2005)
Early prediction of pharmaceutical oxidation pathways by computational chemistry and forced degradation
DL Reid et al.
PHARMACEUTICAL RESEARCH (2004)
LC-MS and NMR determination of a dichloromethane artifact adduct, cyproheptadine chloromethochloride
M Li et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2003)
Copper complexes for catalytic, aerobic oxidation of hydrocarbons
S Murahashi et al.
PURE AND APPLIED CHEMISTRY (2001)
What is the true solubility advantage for amorphous pharmaceuticals?
BC Hancock et al.
PHARMACEUTICAL RESEARCH (2000)
分享论文
